Helping patients with intermediate-risk thyroid cancer make decisions about radioactive iodine treatment
Use of a decision aid to resolve uncertainty about radioactive iodine treatment in patients with intermediate-risk thyroid cancer: the Radiance trial
This study is here to help people with intermediate-risk thyroid cancer understand the pros and cons of using radioactive iodine treatment after surgery, so they can make informed choices about their care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-11225699 on NIH RePORTER |
What this research studies
This research aims to assist patients diagnosed with intermediate-risk differentiated thyroid cancer in understanding the risks and benefits of radioactive iodine (RAI) treatment. It addresses the uncertainty many patients face when deciding between surgery alone or surgery combined with RAI, which can have significant side effects. The study will utilize a decision aid to provide clear information about potential outcomes, side effects, and quality of life impacts associated with RAI. By focusing on patient-centered decision-making, the research seeks to empower individuals to make informed choices regarding their treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with intermediate-risk differentiated thyroid cancer who are considering treatment options.
Not a fit: Patients with low-risk or high-risk differentiated thyroid cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better-informed treatment decisions and improved quality of life for patients with intermediate-risk thyroid cancer.
How similar studies have performed: Previous research has shown that decision aids can effectively improve patient understanding and satisfaction in treatment choices, indicating a promising approach in this context.
Where this research is happening
Washington, United States
- Georgetown University — Washington, United States (Active)
Researchers
- Principal investigator: Jonklaas, Jacqueline — Georgetown University
- Study coordinator: Jonklaas, Jacqueline
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.